Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Citrulline

Metabolic Disorders

CITPlasma citrullineSerum citrulline

Review status

Currently under review

Pending specialist review and validation.

What it shows

Citrulline is an amino acid made mostly by the cells that line your small intestine. It is also a key intermediate in the urea cycle, the process your body uses to convert ammonia, a waste product of protein metabolism, into urea for safe removal in urine.

This test measures the amount of citrulline in your blood plasma. Because citrulline reflects both small intestinal function and urea cycle activity, it can give your care team insight into metabolic health and the integrity of your intestinal lining.

Why it matters

Clinicians use plasma citrulline to help evaluate suspected urea cycle disorders, a group of inherited conditions that affect how the body removes ammonia. It is also useful to assess small intestinal health, since low levels can suggest reduced intestinal mucosal mass that may occur with short bowel syndrome or other causes of intestinal failure.

Your clinician may order this test if you or your child has unexplained vomiting, lethargy, or confusion, particularly in infancy, or if there is concern for metabolic disease. It can also be used to monitor intestinal recovery after surgery or transplant, and to track enteral nutrition response in conditions that damage the small intestine.

Understanding your results

Your result is interpreted alongside symptoms, medical history, and other laboratory findings such as ammonia and a full plasma amino acid profile. Higher citrulline levels can be seen in some urea cycle enzyme deficiencies, while lower levels can point to reduced small intestinal mucosal mass or impaired intestinal function. Kidney and liver function, as well as recent supplements, can influence the value.

If your result is outside the expected range, your clinician may repeat the test, review medications and supplements, and consider additional testing. This may include ammonia testing, other amino acids, urine orotic acid, imaging, or genetic testing. Treatment plans are individualized and may involve diet changes, medications to manage ammonia, or nutrition support if intestinal function is reduced.

Reference ranges

1432 umol/L
All sexes
0 days – 2 years
1735 umol/L
All sexes
2 years – 6 years
2337 umol/L
All sexes
6 years – 14 years
2339 umol/L
All sexes
14 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Citrulline

  • Fasting and timing

    An overnight fast and a morning draw help standardize results, since recent meals or protein drinks can transiently change amino acid levels.

  • Supplements and sports products

    L-citrulline, L-arginine, nitric oxide boosters, and watermelon or other high-arginine foods may raise citrulline temporarily; tell your clinician about all products you use.

  • Medications

    Some drugs, such as valproate and certain chemotherapy agents, can affect amino acid metabolism or intestinal mucosa; your care team will interpret results in that context.

  • Kidney and liver function

    Citrulline is cleared by the kidneys and is part of the urea cycle; reduced kidney function can increase levels, while severe liver disease may alter related metabolites.

  • Intestinal disease or surgery

    Short bowel syndrome, active celiac disease, inflammatory bowel disease, radiation enteritis, or recent intestinal surgery can lower citrulline by reducing enterocyte mass.

  • Sample handling

    Proper tube selection, prompt plasma separation, and cold storage are important; delays or improper handling can lead to inaccurate results.

2026

References

  1. McGill University Health Centre. (2015, February 04). Citrulline (Task CD 17080865). Laboratory reference ranges.
  2. Häberle, J., Burlina, A., Chakrapani, A., Dixon, M., Karall, D., Lindner, M., Rubio, V., & Summar, M. (2019). Suggested guidelines for the diagnosis and management of urea cycle disorders: Second revision. Journal of Inherited Metabolic Disease, 42(6), 1192–1230.
  3. Crenn, P., Coudray-Lucas, C., Thuillier, F., Cynober, L., & Messing, B. (2000). Postabsorptive plasma citrulline concentration is a marker of enterocyte mass and intestinal failure in humans. Gastroenterology, 119(6), 1496–1505.
  4. Crenn, P., Messing, B., & Cynober, L. (2008). Citrulline as a marker of intestinal failure and recovery. Clinical Nutrition, 27(3), 328–339.